| Literature DB >> 23509639 |
Preethi Mathew1, Kerstin Pannek, Pamela Snow, M Giulia D'Acunto, Andrea Guzzetta, Stephen E Rose, Paul B Colditz, Simon Finnigan.
Abstract
BACKGROUND: The etiology of motor impairments in preterm infants is multifactorial and incompletely understood. Whether corpus callosum development is related to impaired motor function is unclear. Potential associations between motor-related measures and diffusion tensor imaging (DTI) of the corpus callosum in preterm infants were explored.Entities:
Mesh:
Year: 2013 PMID: 23509639 PMCID: PMC3569930 DOI: 10.1155/2013/359532
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Descriptive data pertaining to infant characteristics, clinical assessment scores, and GA at assessments.
| Mean | Range | |
|---|---|---|
| GA at birth | 31.2 weeks | 28.6–32.6 weeks |
| Birth weight | 1486.8 g | 1064–1717 g |
| Total HNE score | 22.3 | 15.5–28.0 |
| Motor-specific score | 12.9 | 8.0–18.0 |
| GA at clinical assessment | 42.2 weeks | 41.1–44.6 weeks |
| GA at MRI | 42.7 weeks | 41.1–44.6 weeks |
Figure 1Corpus callosum segmentation schema adapted for neonates by Thompson et al. [10]. RB: rostral body; AMB: anterior midbody; PMB: posterior midbody.
Corpus callosum fractional anisotropy values for each infant.
| Genu | Rostral body | Anterior midbody | Posterior midbody | Isthmus | Splenium | |
|---|---|---|---|---|---|---|
| Infant 1 | 0.35 | 0.29 | 0.34 | 0.46 | 0.32 | 0.39 |
| Infant 2 | 0.35 | 0.37 | 0.40 | 0.33 | 0.32 | 0.49 |
| Infant 3 | 0.36 | 0.32 | 0.38 | 0.30 | 0.32 | 0.39 |
| Infant 4 | 0.38 | 0.34 | 0.39 | 0.31 | 0.29 | 0.41 |
| Infant 5 | 0.35 | 0.34 | 0.38 | 0.42 | 0.33 | 0.44 |
| Infant 6 | 0.35 | 0.37 | 0.42 | 0.49 | 0.47 | 0.48 |
| Infant 7 | 0.38 | 0.37 | 0.37 | 0.36 | 0.37 | 0.45 |
| Infant 8 | 0.36 | 0.34 | 0.33 | 0.35 | 0.42 | 0.44 |
Corpus callosum mean diffusivity values for each infant.
| Genu | Rostral body | Anterior midbody | Posterior midbody | Isthmus | Splenium | |
|---|---|---|---|---|---|---|
| Infant 1 | 0.0016 | 0.0018 | 0.0016 | 0.0014 | 0.0016 | 0.0015 |
| Infant 2 | 0.0016 | 0.0014 | 0.0014 | 0.0015 | 0.0015 | 0.0015 |
| Infant 3 | 0.0014 | 0.0016 | 0.0014 | 0.0016 | 0.0017 | 0.0017 |
| Infant 4 | 0.0015 | 0.0015 | 0.0015 | 0.0014 | 0.0015 | 0.0015 |
| Infant 5 | 0.0017 | 0.0016 | 0.0015 | 0.0013 | 0.0016 | 0.0014 |
| Infant 6 | 0.0017 | 0.0017 | 0.0016 | 0.0014 | 0.0012 | 0.0015 |
| Infant 7 | 0.0014 | 0.0015 | 0.0015 | 0.0014 | 0.0012 | 0.0012 |
| Infant 8 | 0.0015 | 0.0017 | 0.0018 | 0.0017 | 0.0013 | 0.0013 |
Correlation between clinical scores and corpus callosum FA measures.
| Fractional anisotropy | ||||||
|---|---|---|---|---|---|---|
| Genu | Rostral body | Anterior midbody | Posterior midbody | Isthmus | Splenium | |
| Total HNE | ||||||
| Rho | 0.000 | 0.476 | 0.929** | −0.333 | −0.476 | 0.381 |
|
| 1.000 | 0.233 | 0.001 | 0.420 | 0.233 | 0.352 |
| Motor-specific | ||||||
| Rho | −0.238 | 0.238 | 0.857** | −0.262 | −0.548 | 0.214 |
|
| 0.570 | 0.570 | 0.007 | 0.531 | 0.160 | 0.610 |
**P < 0.01.
Correlation between clinical scores and corpus callosum MD measures.
| Mean diffusivity | ||||||
|---|---|---|---|---|---|---|
| Genu | Rostral body | Anterior midbody | Posterior midbody | Isthmus | Splenium | |
| Total HNE | ||||||
| Rho | 0.095 | −0.643 | −0.714* | 0.000 | 0.048 | 0.357 |
|
| 0.823 | 0.086 | 0.047 | 1.000 | 0.911 | 0.385 |
| Motor-specific | ||||||
| Rho | 0.190 | −0.405 | −0.595 | 0.119 | 0.214 | 0.595 |
|
| 0.651 | 0.320 | 0.120 | 0.779 | 0.610 | 0.120 |
*P < 0.05.
Figure 2Scatterplot of total HNE scores versus anterior midbody FA (n = 8; spearman's rho = 0.929; P = 0.001).
Figure 3Scatterplot of total HNE scores versus anterior midbody MD (n = 8; spearman's rho = −0.714; P = 0.047).
Figure 4Scatterplot of motor-specific scores and anterior midbody FA (n = 8; spearman's rho = 0.857; P = 0.007).